111

LOTUS PHARMACEUTICAL CO

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪73.41 B‬TWD
‪4.11 B‬TWD
‪16.96 B‬TWD
‪150.80 M‬
Beta (1Y)
0.28

About LOTUS PHARMACEUTICAL CO

CEO
Petar Antonov Vazharov
Headquarters
Taipei
Founded
1966
ISIN
TW0001795003
FIGI
BBG0015S6316
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of generic pharmaceutical products; and the provision of consulting services. It operates under the Generic Drug and Other business segments. The Generic Drug segment focuses on generic pharmaceutical products. The Other segment provides clinical trial and technical services. The company was founded on June 30, 1966 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1795 is 282.5 TWD — it has increased by 0.89% in the past 24 hours. Watch LOTUS PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange LOTUS PHARMACEUTICAL CO stocks are traded under the ticker 1795.
1795 stock has fallen by 6.92% compared to the previous week, the month change is a 10.03% fall, over the last year LOTUS PHARMACEUTICAL CO has showed a 15.67% decrease.
We've gathered analysts' opinions on LOTUS PHARMACEUTICAL CO future price: according to them, 1795 price has a max estimate of 600.00 TWD and a min estimate of 294.00 TWD. Watch 1795 chart and read a more detailed LOTUS PHARMACEUTICAL CO stock forecast: see what analysts think of LOTUS PHARMACEUTICAL CO and suggest that you do with its stocks.
1795 reached its all-time high on May 19, 2023 with the price of 349.5 TWD, and its all-time low was 44.5 TWD and was reached on Mar 23, 2020. View more price dynamics on 1795 chart.
See other stocks reaching their highest and lowest prices.
1795 stock is 2.16% volatile and has beta coefficient of 0.28. Track LOTUS PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is LOTUS PHARMACEUTICAL CO there?
Today LOTUS PHARMACEUTICAL CO has the market capitalization of ‪74.05 B‬, it has decreased by 6.53% over the last week.
Yes, you can track LOTUS PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
LOTUS PHARMACEUTICAL CO is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
1795 earnings for the last quarter are 3.96 TWD per share, whereas the estimation was 3.82 TWD resulting in a 3.78% surprise. The estimated earnings for the next quarter are 5.65 TWD per share. See more details about LOTUS PHARMACEUTICAL CO earnings.
LOTUS PHARMACEUTICAL CO revenue for the last quarter amounts to ‪4.20 B‬ TWD despite the estimated figure of ‪4.29 B‬ TWD. In the next quarter revenue is expected to reach ‪5.14 B‬ TWD.
1795 net income for the last quarter is ‪1.04 B‬ TWD, while the quarter before that showed ‪399.96 M‬ TWD of net income which accounts for 159.10% change. Track more LOTUS PHARMACEUTICAL CO financial stats to get the full picture.
LOTUS PHARMACEUTICAL CO dividend yield was 1.71% in 2023, and payout ratio reached 29.65%. The year before the numbers were 1.41% and 29.84% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LOTUS PHARMACEUTICAL CO EBITDA is ‪5.72 B‬ TWD, and current EBITDA margin is 36.05%. See more stats in LOTUS PHARMACEUTICAL CO financial statements.
Like other stocks, 1795 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LOTUS PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LOTUS PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LOTUS PHARMACEUTICAL CO stock shows the buy signal. See more of LOTUS PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.